The global apheresis equipment market is gaining prominence owing to increasing prevalence of chronic diseases necessitating therapeutic apheresis procedures. Apheresis equipment helps in collection of specific components of blood such as plasma, platelets & leukocytes for various therapeutic treatments such as autoimmune conditions, transplantation, hematology and dermatology treatments.
Apheresis Equipment Market is estimated to be valued at USD 4.76 Bn in 2025 and is expected to reach USD 10.01 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032.
Apheresis equipment is used to separate blood components such as plasma, platelets, leukocytes etc. using centrifugation or filtration processes for collection of targeted component for treatment or research. It helps in collection of high purity plasma for immunoglobulin treatment, collection of pathogen-free platelets for transfusion support and selective removal of leukocytes from blood circulation in conditions of recurrent infections and autoimmune disorders. Growing applications in regenerative medicine like stem cell therapy has also increased demand for Apheresis Equipment Market Growth globally.
Key Takeaways
Asahi Kasei Medical Co., Ltd., Terumo Corporation, Inc., Fenwal, Inc., Haemonetics Corp., Therakos, Inc., B. Braun Melsungen AG, HemaCare Corporation, Haemonetics Corporation, Cerus Corporation, Kawasumi Laboratories, Miltenyi Biotec, NxStage Medical, and Kaneka Medix Corporation
Growing prevalence of chronic diseases worldwide along with rising use of therapeutic apheresis procedures for autoimmune conditions, cancer, transplant procedures and hematology treatments is positively impacting the demand for apheresis equipment. According to estimates, over 420 million people suffered from chronic diseases like diabetes, cancer and CVD in 2021.
Technological advancements in apheresis equipment like automated blood component separators, single use kits and closed system design have improved safety, efficiency and ease of use. Automation has reduced procedural time and risk of contamination. New modalities like rapid plasma separation have further augmented the market.
Market Trends
Growing popularity of therapeutic plasma exchange (TPE) – TPE is increasingly used for treatment of autoimmune and neurologic disorders including Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis and thrombotic thrombocytopenic purpura. Increasing use of TPE procedures worldwide drives demand for apheresis equipment.
Increasing number of blood component transfusions – Growing incidences of trauma, cancer, transplant surgeries and rising platelet and plasma transfusions globally is translating into increased installation of apheresis equipment in blood banks and transfusion centers.
Market Opportunities
Emerging economies in Asia Pacific and Latin America represent high growth opportunities for players. Improving access to healthcare along with rising healthcare spending can boost adoption of high-end therapeutic apheresis equipment in these regions.
Growing applications of blood components like fresh frozen plasma (FFP) and cryoprecipitate in trauma, obstetrics are requiring frequent use of apheresis equipment in collection centers as well as hospitals.
Impact of COVID-19 on Apheresis Equipment Market Growth
The COVID-19 pandemic has significantly impacted the growth of the apheresis equipment market. During the initial months of the pandemic, many non-urgent medical procedures and outpatient hospital visits were postponed to focus on the COVID-19 infected patients. This negatively affected the demand for apheresis equipment for collecting blood components as well as therapeutic apheresis procedures. However, as the pandemic progressed, the demand for apheresis equipment grew substantially. There was an urgent need for plasma collection from recovered COVID-19 patients for plasma therapy trials to treat infected patients. Many blood centers and hospitals increased their plasma collection targets using apheresis equipment. The demand is expected to remain high even in the post-pandemic period as research on convalescent plasma therapy is still ongoing.
Geographical Regions with Highest Value Concentration of Apheresis Equipment Market
North America region accounts for the largest share of the global apheresis equipment market in terms of value. This is mainly attributed to the presence of advanced healthcare infrastructure and high patient awareness levels regarding blood disorders and their treatment options in countries like the US and Canada. In addition, favorable reimbursement policies for plasma derived therapies and high adoption of latest medical technologies further boost the North America apheresis equipment market. Nearly 50% of the global annual plasma collection is done in the US alone using advanced apheresis equipment.
Fastest Growing Region for Apheresis Equipment Market
Asia Pacific region is poised to witness the fastest growth in the apheresis equipment market during the forecast period. Factors such as rising incidences of chronic diseases, growing geriatric population, increasing healthcare spending, rising medical tourism and emergence of multi-specialty hospitals with state-of-art infrastructure are fueling the demand for therapeutic apheresis procedures in Asia Pacific countries. Countries like China, Japan and India represent high growth opportunities due to huge patient population and expanding medical device industry. Government initiatives to modernize blood collection centers with automated blood component separators will further propel the Asia Pacific apheresis equipment market.
Get More Insights On – Apheresis Equipment Market
Get this Report in Japanese Language – アフェレシス機器市場
Get this Report in Korean Language – 아페리시스 장비 시장
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163